Purpose: A major problem in treating patients with peritoneal spread from colorectal cancer is that at diagnosis wide peritoneal involvement often precludes all curative attempts. A possible solution is to identify those patients at risk for peritoneal metastases and intervene early to prevent locoregional disease spread before it develops and, thus, to improve outcome. Methods: We analyzed long-term results from a previous study and compared outcomes in 25 patients with advanced colon cancer considered at high risk for peritoneal spread (pT3/pT4 and mucinous or signet ring cell histology) prospectively included and managed with a proactive surgical approach including target organ resection for peritoneal spread plus hyperthermic intraperit...
Introduction: Cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) improve the surviv...
Peritoneum is one of the common sites of metastasis in advanced stage colorectal cancer patients. Co...
Copyright © 2013 Yutaka Yonemura et al. This is an open access article distributed under the Creativ...
The study compared the outcome in patients with advanced colonic cancer at high risk of peritoneal m...
PURPOSE Colorectal cancer (CRC) has potential to spread within the peritoneal cavity, and this tr...
Multimodal treatment, including systemic treatment and surgery, improved the prognosis of peritoneal...
Introduction: Population-based data on metachronous peritoneal carcinomatosis (PC) after curative re...
BACKGROUND: TNM stage has been identified as an independent variable for local recurrence and survi...
BACKGROUND Multimodal treatment, including systemic treatment and surgery, improved the prognosis...
Introduction: With evolving treatment strategies aiming at prevention or early detection of metachro...
Patients with locally advanced (T4) colon cancer constitute a challenging patient group, with R0 res...
Treatment possibilities for colorectal peritoneal metastases (PM) are increasing. It is however uncl...
textabstractBackground: The peritoneum is the second most common site of recurrence in colorectal ca...
International audienceBackground Diagnosis and treatment of colorectal peritoneal metastases at an e...
Introduction: Cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) improve the surviv...
Peritoneum is one of the common sites of metastasis in advanced stage colorectal cancer patients. Co...
Copyright © 2013 Yutaka Yonemura et al. This is an open access article distributed under the Creativ...
The study compared the outcome in patients with advanced colonic cancer at high risk of peritoneal m...
PURPOSE Colorectal cancer (CRC) has potential to spread within the peritoneal cavity, and this tr...
Multimodal treatment, including systemic treatment and surgery, improved the prognosis of peritoneal...
Introduction: Population-based data on metachronous peritoneal carcinomatosis (PC) after curative re...
BACKGROUND: TNM stage has been identified as an independent variable for local recurrence and survi...
BACKGROUND Multimodal treatment, including systemic treatment and surgery, improved the prognosis...
Introduction: With evolving treatment strategies aiming at prevention or early detection of metachro...
Patients with locally advanced (T4) colon cancer constitute a challenging patient group, with R0 res...
Treatment possibilities for colorectal peritoneal metastases (PM) are increasing. It is however uncl...
textabstractBackground: The peritoneum is the second most common site of recurrence in colorectal ca...
International audienceBackground Diagnosis and treatment of colorectal peritoneal metastases at an e...
Introduction: Cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) improve the surviv...
Peritoneum is one of the common sites of metastasis in advanced stage colorectal cancer patients. Co...
Copyright © 2013 Yutaka Yonemura et al. This is an open access article distributed under the Creativ...